Metraipolis › archive › dc_57ef0ecd7d7b

Adaptive dosing of immunotherapy plus anti-angiogenic therapy in a nonagenarian with hepatocellular carcinoma: a case report with 10-year survival — Europe PMC PMID:42620715

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42620715
DOI
10.3389/fonc.2026.1833336
License (as archived)
solo-consultazione
Archived
2026-10-17T03:11:59.526Z
SHA-256 of the archived text
4748823e983fa1ddad2ae4a73f54d706b1300204c8059da652dd3468ddb070b9
Stable URL of this page
https://metraipolis.com/documento/dc_57ef0ecd7d7b

How to cite

Adaptive dosing of immunotherapy plus anti-angiogenic therapy in a nonagenarian with hepatocellular carcinoma: a case report with 10-year survival — Europe PMC PMID:42620715 — Europe PMC (en), https://europepmc.org/article/MED/42620715 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57ef0ecd7d7b (Metraipolis archive dc_57ef0ecd7d7b, sha256 4748823e983fa1ddad2ae4a73f54d706b1300204c8059da652dd3468ddb070b9)
BibTeX
@misc{dc57ef0ecd7d7b,
  title = {Adaptive dosing of immunotherapy plus anti-angiogenic therapy in a nonagenarian with hepatocellular carcinoma: a case report with 10-year survival — Europe PMC PMID:42620715},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42620715},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57ef0ecd7d7b; sha256 4748823e983fa1ddad2ae4a73f54d706b1300204c8059da652dd3468ddb070b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42620715. Agents can read the archived copy with the MCP tool read_document.